| AMTI |    | Applied Molecular Transport Inc. - common stock | | | -15.74% -15.74% 0 | | + Biology, Medicine, Disease: Debilitating
Last highlighted: #AMTI SEC report: Applied Molecular Transport Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Applied Molecular Transport Inc. -- SEC File Number | + My List |
| ARDX | | Ardelyx, Inc. - Common Stock | | | -13.73% -13.73% 0 | | + Biology, Medicine
Last highlighted: Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC $ARDX https://t.co/dIF5vLJfQt | + My List |
| AXLA | | Axcella Health Inc. - Common Stock | | | -2.03% down 8.03% -10.06 | | + Medicine, Biology, Disease: Metabolic disorders
| + My List |
| BLFS | | BioLife Solutions, Inc. - Common Stock | | | -9.49% -9.49% 0 | | + Medicine, Biology
| + My List |
| CFRX | | ContraFect Corporation - Common Stock | | | -1.54% down 10.17% -11.71 | | + Biology, Medicine, Disease: Infectious
| + My List |
| DVAX | | Dynavax Technologies Corporation - Common Stock | | | 1.58% down 9.55% -7.97 | | + Immunology, Biology, Biopharma, Medicine, Vaccines
Last highlighted: #DVAX SEC report: DYNAVAX TECHNOLOGIES CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by DYNAVAX TECHNOLOGIES CORP -- SEC File Number | + My List |
| EQ | | Equillium, Inc. - Common Stock | | | 7.79% 7.79% 0 | | + Biology, Medicine
| + My List |
| EVGN | | Evogene Ltd. - Ordinary Shares | | | -13.59% -13.59% 0 | | + Medicine, Biology, Artificial Intelligence
Last highlighted: #EVGN SEC report: Evogene Ltd. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evogene Ltd. -- SEC File Number 211161875 | + My List |
| FLDM | | Fluidigm Corporation - Common Stock | | | -7.02% -7.02% 0 | | + Life Sciences, Biology, Cancer fight, Biotechnology, RNA
Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270 | + My List |
| ILMN | | Illumina, Inc. - Common Stock | | | -6.04% up -20.6% 14.56 | | + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health
Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268 | + My List |
| LIFE | | aTyr Pharma, Inc. - Common Stock | | | -2.89% up -8.14% 5.25 | | + Biology, RNA, Medicine
| + My List |
| QTRX | | Quanterix Corporation - Common Stock | | | up -8.08% 8.08 | | + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology
Last highlighted: #QTRX SEC report: Quanterix Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Quanterix Corp -- SEC File Number | + My List |
| SELB | | Selecta Biosciences, Inc. - Common Stock | | | up -9.71% 9.71 | | + Biotechnology, Immunology, Biology, Medicine
Last highlighted: $SELB Selecta Biosciences, Inc. SEC Filing: Form 8-K https://t.co/0XklTmmzMS | + My List |
| SONN | | Sonnet BioTherapeutics Holdings, Inc. - Common Stock | | | 0 | | + Cancer fight, Biology, Medicine
| + My List |
| SYBX | | Synlogic, Inc. - Common Stock | | | 4.5% up -9.17% 13.67 | | + Biology, Medicine
| + My List |
| ZNTL | | Zentalis Pharmaceuticals, Inc. - common stock | | | 4.73% down 18.04% -13.31 | | + Cancer fight, Biology, Pharmaceutical , Medicine
Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number | + My List |
| ABCL | | AbCellera Biologics Inc. - Common Shares | | | 6.92% down 10.66% -3.74 | | + Medicine, Biology
Last highlighted: #ABCL SEC report: AbCellera Biologics Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by AbCellera Biologics Inc. -- SEC File Number 211088168 | + My List |
| ADAG | | Adagene Inc. - ADS, each representing 1.25 ordinary shares | | | -1.37% -1.37% 0 | | + Medicine, Biology
Last highlighted: $ADAG 6-K Adagene (7 Jul, 7:52am)
📰 Adagene Announces Authorization of Share Repurchase Program up to US$20 Million
https://t.co/QHy8NXROk9
#ADAG #6K #Adagene #News | + My List |
| EVAX | | Evaxion Biotech A/S - American Depositary Share | | | 6.15% down 7.45% -1.3 | | + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology
Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935 | + My List |
| OLK | | Olink Holding AB (publ) - American Depositary Shares | | | 6.18% down 7.05% -0.87 | | + Biology, Biopharma, Medicine, Country: Sweden
Last highlighted: #OLK SEC report: Olink Holding AB Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Olink Holding AB -- SEC File Number 211161931 | + My List |